All In Biotech

Drug Trial Radar · NCT00435591

A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

A Phase 4, Randomized, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Last checked: Nov 19, 2026Latest source record: May 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Jan 2007

Primary completion

Sep 2008

Study completion Sep 2008

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Feb 15, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia

Conditions

  • Hyponatremia
  • Euvolemia
  • Hypervolemia

Interventions

  • ConivaptanDrug

    ampoule or premix bag

  • placeboDrug

    ampoule or premix bag

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Severity of Infusion Site Reactions (ISRs) Using a Modified ISR Reporting Scale for Phlebitis and Infiltration in Patients Treated With Dose Regimen 1 and Dose Regimen 2Time frame: 48 hours

Locations

18 sites in 3 countries. Site status is shown where the registry gives one.

  • Site not named

    Charleston, South Carolina

  • Site not named

    Bangalore, India

  • Site not named

    Bangalore, India

  • Site not named

    Bhopal, India

  • Site not named

    Hyderabaad, India

  • Site not named

    Karnāl, India

  • Site not named

    Afula, Israel

  • Site not named

    Ashkelon, Israel

  • Site not named

    Haifa, Israel

  • Site not named

    Haifa, Israel

  • Site not named

    Holon, Israel

  • Site not named

    Jerusalem, Israel

  • Site not named

    Jerusalem, Israel

  • Site not named

    Rehovot, Israel

  • Site not named

    Safed, Israel

  • Site not named

    Tel Aviv, Israel

  • Site not named

    Tel HaShomer, Israel

  • Site not named

    Tsrifin, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.